NanoViricides, Inc (NNVC) FinancialsNNVCNanoViricides, Inc

Evaluating the bottom line, NanoViricides, Inc maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -101.46%, provide a clear picture of how effectively NNVC converts its operational activities into shareholder value.

In the context of the broader market, NNVC competes directly with industry leaders such as LITS and EDSA. With a market capitalization of $33.95M, it holds a leading position in the sector. When comparing efficiency, NNVC's gross margin of N/A stands against LITS's N/A and EDSA's N/A. Such benchmarking helps identify whether NanoViricides, Inc is trading at a premium or discount relative to its financial performance.

The company has been experiencing consistent net income losses, with Q4 2026 reporting a loss of $2,223,399. The gross profit has also been negative in recent quarters, indicating ongoing financial challenges.